Content about Pharmaceuticals in India

September 1, 2011
FTC: Authorized generics reduce overall drug prices

Branded drugs sold under their generic names at a reduced price can reduce retail and wholesale drug prices, according to a new report by the Federal Trade Commission.

August 24, 2011
Par to acquire Anchen

Par Pharmaceutical Cos. will acquire Anchen Pharmaceuticals for $410 million, Par said Wednesday.

July 28, 2011
Sanofi announces executive changes

The president and CEO of Sanofi's U.S. operations is stepping into a newly created role at the drug maker.

July 26, 2011
Watson garners 24% increase in Q2 sales

Watson Pharmaceuticals had sales of $1.1 billion during second quarter 2011, the generic drug maker said.

June 28, 2011
Hi-Tech Pharmacal acquires rights to branded drugs

Generic drug maker Hi-Tech Pharmacal said that it has acquired marketing and distribution rights to pain treatments made by Atley Pharmaceuticals.

June 20, 2011
FDA panel unanimously recommends approval of Eylea

A panel of Food and Drug Administration experts has recommended approval of an investigational biotech drug made by Regeneron Pharmaceuticals for eye diseases.

June 15, 2011
Watson confirms patent challenge for generic Pataday

Watson Pharmaceuticals has filed a regulatory approval application with the Food and Drug Administration for a generic drug for eye disease, the company said Tuesday.

June 7, 2011
HDMA announces 2011 DIANA winners

The Healthcare Distribution Management Association on Monday awarded eight leading pharmaceutical and consumer product manufacturers through the presentation of its annual Distribution Industry Awards for Notable Achievements in health care.

May 26, 2011
J&J looks to boost product portfolio, seeks regulatory approval for 11 new drugs

Drug maker Johnson & Johnson plans to file for regulatory approval for 11 new drugs between 2011 and 2015, the company said Thursday in relation to a meeting between J&J’s executive committee and investors.

April 21, 2011
Report: Lupin's generic Fortamet receives FDA nod

The Food and Drug Administration has approved a diabetes drug made by Lupin Pharmaceuticals, according to published reports.

April 6, 2011
Salix, Lupin ink technology deal for Xifaxan

Indian drug maker Lupin and U.S. drug maker Salix Pharmaceuticals announced Wednesday a licensing deal for technology related to a drug for traveler’s diarrhea.

March 21, 2011
GPhA responds to potential OGD funding cuts; announces exit of Gordon Johnston

The generic drug industry’s main lobby in Washington is hoping to head off cuts to the Food and Drug Administration’s Office of Generic Drugs, which it said could have a “devastating impact” on those who rely on generics.

January 4, 2011
Pfizer inks deal with Santaris

Pfizer will pay Danish biotech company Santaris Pharma $14 million for access to its development platform for RNA-based therapies, Pfizer said Tuesday.

November 30, 2010
Ranbaxy launches generic Aricept

Ranbaxy Pharmaceuticals has received final approval for its generic Alzheimer's drug from the Food and Drug Administration, giving the drug maker 180 days of market exclusivity.

November 14, 2010
Patent cliff to bring short-term boon to generic industry

Look for a big surge in brand-to-generic drug switches at the pharmacy counter over the...

November 9, 2010
Eden, Crucell ink manufacturing agreement

Watson Pharmaceuticals biotech subsidiary Eden Biodesign has signed a manufacturing agreement with Dutch biotech company...

November 2, 2010
AmerisourceBergen fares well in Q4, FY2010

Earnings per share for AmerisourceBergen rose nearly 14% during the fourth quarter ended Sept. 30,...

November 2, 2010
Lupin's generic Clarinex gets FDA approval

The Food and Drug Administration has approved a generic treatment made by Lupin Pharmaceuticals for...

October 20, 2010
K-V establishes generic drug subsidiary Nesher Pharmaceuticals

K-V Pharmaceutical has created a new marketing subsidiary for generic drugs, the company said Wednesday....

October 11, 2010
Pfizer to acquire King Pharmaceuticals

Pfizer will buy King Pharmaceuticals for $3.6 billion, Pfizer said Tuesday....

September 27, 2010
Endo boosts portfolio with Qualitest acquisition

Endo Pharmaceuticals will acquire generic drug maker Qualitest Pharmaceuticals for $1.2 billion, Endo said Tuesday....

September 26, 2010
NACDS conference discusses patent cliff, future of generics

Winc Design is launching its Charlie Banana brand of environmentally friendly cloth diapers and baby...

September 26, 2010
Q&A: A dose of generic Meda-cine

Many generic drug companies have long marketed branded drugs on the side, but lately, some...

September 7, 2010
GSK inks deal with Lonza, announces CFO's exit

Swiss drug maker Lonza will help British drug maker GlaxoSmithKline manufacture five biotech drugs in...

August 9, 2010
Revenue, profit rise for Watson in Q2

Generic drug maker Watson Pharmaceuticals posted strong sales for second quarter 2010, according to an...

© 2013 Drug Store News. All Rights Reserved.